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ABSTRACT
The largely unused uracil-excision molecular clon-
ing technique has excellent features in most aspects
compared to other modern cloning techniques. Its
application has, however, been hampered by incom-
patibility with proof-reading DNA polymerases. We
have advanced the technique by identifying PfuCx
as a compatible proof-reading DNA polymerase and
by developing an improved vector design strategy.
The original features of the technique, namely sim-
plicity, speed, high efficiency and low cost are thus
combined with high fidelity as well as a transparent,
simple and flexible vector design. A comprehens-
ive set of vectors has been constructed covering
a wide range of different applications and their
functionality has been confirmed.
INTRODUCTION
The principle of uracil-excision based cloning, which was
conceived in the early 1990s (1,2), has in 2003 resulted in
a commercial method, the USER  (uracil-speciﬁc excision
reagent) cloning technique (New England Biolabs). Brieﬂy,
in the commercial technique the cloning event relies on the
ability of 8 nt long complementary 30 overhangs generated
at the ends of, respectively, a PCR ampliﬁed DNA fragment
and a linearized destination vector to make a stable hybridiza-
tion product, which can be used to transform host organisms
without prior ligation. These overhangs are generated on
PCR fragments by placing a single uracil residue in each
primer used to amplify the target DNA and subsequently
treating the resulting PCR product brieﬂy with uracil DNA
glycosylase (2) and DNA glycosylase-lyase Endo VIII.
These enzymes, which are included in the USER  enzyme
mix, remove the two single uracil residues and enable the
dissociation of the single-stranded fragments lying upstream
from the cleavage sites (exempliﬁed in Figure 1).
The commercial USER  technique enjoys a large number
of advantageous features. Most prominent is its simplicity.
Primers for amplifying PCR fragments need only to have
8 bp tails added to their speciﬁc sequence and the vector
design involves simple insertion of a small cassette into the
multiple cloning site of already established vectors. Another
strong feature of the technique is the strength by which the
long overhangs on PCR fragment anneal to the complemen-
tary overhangs on the vector to generate recombinant DNA
molecules in a ligation independent manner at a very high
efﬁciency. Furthermore, the technique involves minimal han-
dling and is very robust as PCR products at a wide range of
concentrations can be mixed directly with USER  enzyme
mix and a predigested stock of linearized vector without
puriﬁcation or further modiﬁcations to give the recombinant
molecules. This makes the technique highly suitable for sin-
gle as well as high-throughput cloning experiments of PCR
fragments.
In spite of these advantages, we have not found a single
published work using the commercial USER  technique,
which indicates that the method is largely unused. This is
most likely due to an incompatibility between the technique
and proof-reading DNA polymerases, which stall at uracils
present in DNA templates (3,4). Consequently, only the low-
ﬁdelity Taq based polymerases have been applicable, which
has made the cloning of error-free DNA difﬁcult. This
negates all advantageous features and practically renders
the technique close to useless.
In this study, we have identiﬁed a proof-reading DNA poly-
merase that is compatible with the uracil-excision based clon-
ing technique and we provide an improved, versatile vector
design strategy. The advances allow the great potential of
the technique to be fully exploited.
MATERIALS AND METHODS
PCR conditions
PCR with the following DNA polymerases: HotMaster 
Taq DNA Polymerase (Eppendorf), Platinum  Taq DNA
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doi:10.1093/nar/gkl635Polymerase (Invitrogen), Pwo DNA Polymerase (Roche),
Phusion  DNA Polymerase (Finnzymes), and PfuTurbo 
Cx Hotstart DNA polymerase (PfuCx) (Stratagene) was
performed according to manufacturers’ instructions on
pBAD-TOPO  (Invitrogen) containing the gene, At5g43440
(Accession no. AY143873 ). The following primer combina-
tions used were: Uracil-free forward primer: (50-ATGACAG-
AAAAATCTGCAGAACT-30), uracil-free reverse primer:
(50-TCATATCCGGAACTTAGACAA-30), uracil-containing
forward primer: (50-GGCTTAAUATGACAGAAAAAT-
CTGCAGAACT-30) and uracil-containing reverse primer:
(50-GGTTTAAUTCATATCCGGAACTTAGACAA-30). All
oligonucleotides used in this study were acquired from
Invitrogen.
Generation of USER compatible vectors
Chemically synthesized oligonucleotide cassettes composing
the PacI cassette were cloned into various destination vectors
using standard molecular biology methods. Forward strand:
(50-restriction enzyme site + GGCTGAGGCTTAATTAAG-
GATCCTTAATTAAACCTCAGC-30) and reverse strand:
(50-restriction enzyme site + GGCTGAGGTTTAATTAAG-
GATCCTTAATTAAGCCTCAGC-30). The resulting USER
compatible constructs were veriﬁed by sequencing (for
extended tables including the corresponding oligonucleotides
used to construct each USER vector described in this study
see Supplementary Data).
Preparing USER vectors for cloning
The PacI cassette-containing vector is prepared for cloning
by digesting with PacI and subsequent nicking by Nt.BbvCI.
Prolonged digestion is performed to ensure complete diges-
tion, which minimizes false positive colonies and increases
cloning efﬁciency. A total of 5 mg plasmid DNA of the con-
structed vectors were digested with 40 U PacI (New England
Biolabs) overnight at 37 C in a total volume of 200 ml.
Additional 20 U of PacI were added the next day together
with 20 U Nt.BbvCI (New England Biolabs), and the diges-
tion was incubated for 2 h at 37 C. The linearized vector was
puriﬁed using the Qiagen PCR puriﬁcation kit.
Insertion of PCR fragments into USER vectors
Any DNA fragment to be inserted into any of our PacI
cassette-containing USER vectors was PCR ampliﬁed with
primers, which in addition to the sequence speciﬁc to the
target DNA fragment contained a tail of 8 nt (see below). For-
ward primer: (50-GGCTTAAU + sequence complementary to
target DNA-30), Reverse primer: (50-GGTTTAAU + sequence
complementary to target DNA-30). For amplifying genes to be
inserted into C-terminal fusion vectors (see below) a reverse
primer was used, which replaced the stop codon with two
cytidine residues. C-terminal fusion reverse primer: (50-
GGTTTAAU + CC + sequence complementary to target
gene upstream of stop codon-30). PCR was performed with
PfuCx DNA polymerase according to manufacturer’s instruc-
tions. Subsequently, a mixture of PCR product, 1 U USER 
enzyme mix (New England Biolabs), and PacI/Nt.BbvCI
digested USER vector was incubated 20 min at 37 C
followed by 20 min at 25 C and ﬁnally transformed into
chemically competent Escherichia coli cells (do not use elec-
troshock transformation). The reaction is very robust and has
high efﬁciency when as little as 0.01 pmol of linearized vector
and >0.02 pmol of PCR fragment are used. In practice, the
concentrations of linearized vector and PCR product were
estimated by gel electrophoresis and mixed in a 1:10 molar
ratio. This ratio is the optimal ratio between vector and PCR
fragment, which gives the largest number of recombinant col-
onies with the lowest proportion of false positives (http://
www.neb.com/nebecomm/ManualFiles/manualE5500.pdf).
In the text, the term ‘USER cloning’ will be used to
describe the steps that involve (i) PCR ampliﬁcation of target
DNA fragment with PfuCx using the primers described above
(ii) mixing of PCR fragment with linearized vector and
USER  enzyme mix and (iii) transformation of E.coli.
Generation of USER compatible translational fusion
vectors by sequential USER cloning of multiple inserts
PacI cassettes were regenerated when USER cloning into the
PacI cassette of existing USER vectors by including 25 bp of
the 38 bp PacI cassette sequence in the end of inserted DNA
fragments. The 25 bp regenerate the PacI cassette either
upstream or downstream from the inserted DNA fragment
depending on, in which end of the DNA fragment the
25 bp is incorporated.
Vectors for N-translational fusions were made by USER
cloning tags into USER compatible vectors while regenerating
the PacI cassette downstream of the tag. PCR ampliﬁcation of
the tags was performed with PfuCx DNA polymerase as
described above using a normal forward primer (50-GG-
CTTAAU + tag ORF speciﬁc sequence-30) and a reverse
primer which included 25 additional bases (underlined) that
Figure 1. Overview of the USER cloning technique. A PacI cassette
containing USER vector (upper left corner) is digested with PacI and
Nt.BbvCI to generate 8 nt single-stranded 30 overhangs. A PCR fragment
amplified with compatible uracil-containing primers by the PfuTurbo  Cx
Hotstart DNA polymerase is mixed with USER  enzyme mix (removing
uracils, pink) and the linearized vector. The mixture is incubated 20 min
at 37 C and 20 min at 25 C, and the hybridized product is ready to be
transformed into E.coli without prior ligation. Nt.BbvCI recognition sites
are marked in tan, PacI recognition sites are marked in light blue. Yellow and
green mark single base differences between the generated 30 overhangs,
which are responsible for the directional insertion of the PCR fragment.
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insertion (50-GGTTTAAUTAAGGATCCTTAATTAAGCC-
TCAGCCC + tag ORF speciﬁc sequence-30). Between the
25 bases and the tag ORF speciﬁc sequence, two cytidine
residues have been added (italic) to bring the subsequently
inserted gene into the same reading frame as the tag. Short
tags can be synthesized as oligonucleotides and USER cloned
into PacI cassette containing vectors to create N-terminal
translational fusions. Forward strand: (50-GGCTTAAU + tag
ORF coding strand + GGGCTGAGGCTTAATTAAGG-
ATCCTTAATTAAACC-30) and reverse strand: (50-GGTT-
TAAUTAAGGATCCTTAATTAAGCCTCAGCCC + tag
ORF complementary strand + ATTAAGCC-30).
For USER cloning genes into N-terminal fusion vectors,
genes were PCR ampliﬁed with normal forward primer: (50-
GGCTTAAU + sequence complementary to target DNA-30)
and normal reverse primer: (50-GGtTTAAU + sequence
complementary to target DNA-30) and USER cloned into
the vectors as described above.
Vectors for C-terminal translational fusions were made by
inserting tags that were PCR ampliﬁed using a forward
primer: (50-GGCTTAAUTAAGGATCCTTAATTAAACCT-
CAGC + tag ORF speciﬁc sequence-30), which regenerate
the PacI cassette upstream of the tag and a normal reverse
primer: (50-GGTTTAAU + tag ORF speciﬁc sequence) or by
inserting chemically synthesized oligonucleotides, forward
strand: (50-GGCTTAAUTAAGGATCCTTAATTAAACCT-
CAGC + tag ORF + ATTAAACC-30) and reverse strand:
(50-GGTTTAAU + tag ORF complementary strand + GCT-
GAGGTTTAATTAAGGATCCTTAATTAAGCC-30). For
USER cloning genes into C-terminal fusion vectors, the
native stop codon of the gene was replaced with two cytidine
residues (in the antisense strand) to bring the inserted gene
into reading frame with the downstream tag. Thus, genes
were PCR ampliﬁed with a normal forward primer: (50-
GGCTTAAU + sequence complementary to target DNA-30)
and reverse primer: (50-GGTTTAAU + CC + sequence com-
plementary to target gene upstream of stop codon-30).
USER cloning and expression of cyano fluorescent
protein (CFP) in planta
CFP was USER cloned into the plant speciﬁc pCAMBIA-
230035Su vector (Table 1) as described above with the
primers: UCFP-F: (50-GGCTTAAUATGGTGAGCAAGG-
GCGAGGAG-30) and UCFP-R: (50-GGTTTAAUTTACTTG-
TACAGCTCGTCCATG-30).
The resulting vector construct was subsequently
transformed by electroporation (5) into Agrobacterium
tumefaciens strain C58 (6). Arabidopsis thaliana plants
were transformed by the ﬂoral dip method (7).
USER cloning and expression of AtSTP1 in
Xenopus oocytes
AtSTP1 was USER cloned into the Xenopus laevis expression
vector, pNB1u (Table 1), as described above. PCR ampliﬁ-
cation from pda05545 (Riken BRC) was performed with
the primers: USTP1-F: (50-GGCTTAAUATGCCTGCCGG-
TGGATTC-30) and USTP1-R: (50-GGTTTAAUTCAAAC-
ATGCTTCGTTCC-30). The resulting pNB1u-STP1 plasmid
DNA was linearized with NotI and subsequently in vitro
transcribed using the T7 mMessage mMachine kit (Ambion )
according to the manufacturer’s instructions. Oocytes were
prepared as described previously (8), and subjected to injec-
tion of 50 ng cRNA. Oocytes were incubated for 2–3 days
at 17–18 C, and assayed for transport uptake activity as
described previously (9).
RESULTS
Identification of a uracil compatible proof-reading
DNA polymerase
In a literature search, we sought to understand the structural
basis for the uracil inhibition of proof-reading DNA
polymerases and the resulting incompatibility with uracil-
containing primers. We discovered that a non proof-reading
version of the Pyrococcus furiosus (Pfu) polymerase recently
was engineered to read through uracils present in DNA
templates (10). A version with proof-reading activity of this
polymerase was later found to be commercially available as
the PfuTurbo  Cx Hotstart DNA polymerase. We tested the
ability of the non proof-reading DNA polymerases Hotmaster
Taq, and Taq, as well as the proof-reading DNA polymerases;
Phusion, Pwo and PfuCx to perform with uracil-free and
uracil-containing primers (Figure 2a). The experiment showed
that whereas all ﬁve polymerases accept uracil-free primer
combinations, only the non-proof-reading Taq and the
proof-reading PfuCx polymerases were able to exponentially
amplify templates using uracil-containing primers.
Vector design of USER compatible vectors
Vector design for the commercial USER  cloning technique
involves insertion of a 42 bp cassette which contains two
XbaI restriction recognition sites ﬂanked by two Nt.BbvCI
nicking recognition sites into the multiple cloning sites
(http://www.neb.com/nebecomm/ManualFiles/manualE5500.
pdf). Subsequent digestion of the constructed vector with
these two enzymes generates a linearized fragment with
8n t3 0 overhangs at each end (Figure 1). To be applicable
with the uracil-based cloning technique, it is required for the
restriction enzyme used in the cassette to cut after a thymi-
dine residue in their recognition sequence. This thymidine
residue will be the last residue in the 8 nt 30 overhangs in
the vector and will correspond to the uracil in the PCR pri-
mers (Figure 1). We found that PacI, PmeI, AsiSI and SwaI
fulﬁll this requirement and, in addition, these all have 8 bp
recognition sequences which statistically occur less fre-
quently than the 6 bp restriction site of XbaI. We designed
a 38 bp cassette that has two PacI sites ﬂanked by two
Nt.BbvCI sites at its core (PacI cassette, Figure 1, left panel).
The sequence of the 8 nt 30 overhangs generated in USER
vectors after digestion is mostly dictated by the recognition
sites of the nicking and restriction enzymes used in the cas-
sette. Since the same nicking and restriction recognition
sites are used in both halves of the cassette, directional inser-
tion of DNA fragments is ensured by varying the nucleotides
lying between the respective recognition sites. In the XbaI-
containing cassette, three variable nucleotides lie between
the recognition sites of Nt.BbvCI and XbaI. In our PacI cas-
sette, only one variable nucleotide lies between the Nt.BbvCI
and PacI recognition sites (Figure 1). This could potentially
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# USER vector Origin of vector Organism Promoter Description of application
1 pPICZAu (3.6 kb) pPICZA (Invitrogen) P.pastoris AOX1 Constitutive expression.
Zeocin resistance.
2 pNB1u (3 kb) pNB1 (15) X.laevis oocytes T7 Constitutive expression.
Xenopus b-globin UTRs.
Ampicilin resistance
3 pCAMBIA2300u (8.7 kb) pCAMBIA2300
(www.cambia.org)
Plants None Stable transformation. Suitable for molecular
complementation studies.
Kanamycin resistance.
4 pCAMBIA3300u (8.4 kb) pCAMBIA3300
(www.cambia.org)
Plants None Stable transformation. Suitable for molecular
complementation studies.
Basta resistance.
5 pPS48u (3.5 kb) pPS48 (12) Plants 35S Transient expression.
Ampicilin resistance.
6 pCAMBIA130035Su (9 kb) pCAMBIA1300
(www.cambia.org)
and pPS48 (12)
Plants 35S Stable transformation. Suitable for overexpression studies.
Hygromycin resistance.
7 pCAMBIA230035Su (9.8 kb) pCAMBIA2300
(www.cambia.org)
and pPS48 (12)
Plants 35S Stable transformation. Suitable for overexpression studies.
Kanamycin resistance.
8 pCAMBIA330035Su (9.5 kb) pCAMBIA3300
(www.cambia.org)
and pPS48 (12)
Plants 35S Stable transformation. Suitable for overexpression studies.
Basta resistance.
9 pBGF-0u (15 kb) pBGF-0 (13) Plants None Stable transformation. For promoter-reporter analysis with
a nuclear localized GFP variant.
Kanamycin resistance.
10 pNB1MRGSHis6u (3 kb) pNB1u (this work) X.laevis oocytes T7 For N-terminal fusions to a RGSHis6 tag.
Xenopus b-globin UTRs.
Ampicilin resistance.
11 pNB1YFPu (3.8 kb) pNB1u (this work) X.laevis oocytes T7 For N-terminal fusions to YFP(17).
Xenopus b-globin UTRs.
Ampicilin resistance.
12 pNB1YNu (3.5 kb) pNB1u (this work) X.laevis oocytes T7 For N-terminal fusions to the N-terminal part of YFP for
use in BiFC (17,18).
Xenopus b-globin UTRs.
Ampicilin resistance.
13 pNB1YCu (3.3 kb) pNB1u (this work) X.laevis oocytes T7 For N-terminal fusions to the C-terminal part of YFP for
use in BiFC (17,18).
Xenopus b-globin UTRs.
Ampicilin resistance.
14 pNB1uYFP (3.8 kb) pNB1u (this work) X.laevis oocytes T7 For C-terminal fusions to YFP (17).
Xenopus b-globin UTRs.
Ampicilin resistance
15 pNB1uYN (3.5 kb) pNB1u (this work) X.laevis oocytes T7 For C-terminal fusions to the N-terminal part of YFP for
use in BiFC (17,18).
Xenopus b-globin UTRs.
Ampicilin resistance.
16 pNB1uYC (3.3 kb) pNB1u (this work) X.laevis oocytes T7 For C-terminal fusions to the C-terminal part of YFP
for use in BiFC (17,18).
Xenopus b-globin UTRs.
Ampicilin resistance.
17 pPS48YFPu (4.3 kb) pPS48u (this work) Plants 35S Transient expression. For N-terminal fusions to YFP (17).
Ampicilin resistance.
18 pPS48YNu (4 kb) pPS48u (this work) Plants 35S Transient expression. For N-terminal fusions to N-terminal
part of YFP for use in BiFC (17,18).
Ampicilin resistance.
19 pPS48YCu (3.8 kb) pPS48u (this work) Plants 35S Transient expression. For N-terminal fusions to the
C-terminal part of YFP for use in BiFC (17,18).
Ampicilin resistance.
20 pPS48uYFP (4.3 kb) pPS48u (this work) Plants 35S Transient expression. For C-terminal fusions to YFP (17).
Ampicilin resistance.
21 pPS48uYN (4 kb) pPS48u (this work) Plants 35S Transient expression. For C-terminal fusions to the
N-terminal part of YFP for use in BiFC (17,18).
Ampicilin resistance.
22 pPS48uYC (3.8 kb) pPS48u (this work) Plants 35S Transient expression. For C-terminal fusions to the
C-terminal part of YFP for use in BiFC (17,18).
Ampicilin resistance.
A range of USER vectors has been generated by insertion of PacI. Cassettes (denoted by a ‘u’) into multiple cloning sites of established vectors (vectors 1–9). The
vectors have been used further to generate a comprehensive set of translational fusion vectors (vectors 10–22) by sequential USER cloning. Abbreviations: USER
cloning, see Materials and Methods section for definition. BiFC, bimolecular fluorescence complementation, UTR, untranslated region, YFP/GFP, yellow/green
fluorescence protein.
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a directional fashion. However, we have cloned more than
500 PCR fragments by USER cloning into the described
PacI cassette and have not detected a single fragment that
has been inserted in the wrong direction (data not shown).
Furthermore, calculated Tm values for the hybridizing ends
of fragments inserted in the correct orientation are  22 C
(11) while the corresponding Tm’s for fragments hybridizing
in the wrong orientation are close to 0 C. This indicates that
the single base difference between the otherwise identical
halves of our PacI cassette is sufﬁcient to ensure directional
cloning.
We have sequenced  60 kb and identiﬁed only three
errors, which conﬁrmed the proof reading activity of the
PfuCx polymerase.
Conversion of established vectors to USER vectors
By inserting the described PacI cassette into multiple cloning
sites of established vectors, a collection of USER vectors was
constructed (Table 1). This included vectors for constitutive
expression in Pichia pastoris (AOX1 promoter and Zeocin
resistance), Xenopus oocytes (T7 promoter, b-globin UTRs
and ampicilin resistance), and in planta. The latter included
vectors based on the Cauliﬂower Mosaic Virus (CaMV)
35S promoter and nos terminator (12) using three different
selection markers (kanamycin, hygromycin and basta). In
addition, the PacI cassette was inserted into a plant vector
designed for promoter-reporter analysis using a nuclear local-
ized GFP variant (13) and into plant vectors suitable for
molecular complementation experiments (Table 1).
PacI cassette functionality
When cloning into the generated USER vectors, which
originated from already established vectors, a short 13 bp
sequence was introduced between the inserted DNA fragment
and neighboring vector sequences (Figure 1, bottom). To
ensure that this short 13 bp sequence did not impede the
transcriptional or translational machinery in host organisms,
we functionally expressed the A.thaliana glucose transporter
AtSTP1 (14) in X.laevis oocytes from the generated Xenopus-
speciﬁc USER expression vector, pNB1u (15) and the CFP in
planta from the plant-speciﬁc USER expression vector,
pCAMBIA230035Su (Table 1). AtSTP1-expressing oocytes
exhibited the expected glucose transport activity compared
to uninjected oocytes (Figure 2b) (16). Similarly, several
independent transgenic plants expressing CFP exhibited
a clear ﬂuorescence compared to empty vector controls
(Figure 2c). This indicated that the 13 bp did not impede
the transcriptional or translational machinery in the two
different host organisms.
Sequential USER cloning of multiple insertions
The commercial USER cloning approach allows insertion of
only one DNA fragment into compatible vectors. We have
developed a method for sequential USER cloning of multiple
fragments into a vector once this has had the 38 bp PacI cas-
sette inserted. The method is based on including 25 bp of the
PacI cassette in the sequence of the inserted DNA fragment
either through PCR or in chemically synthesized fragments
(Figure 3). Together with the 8 nt overhang and the remaining
5 bp of the Nt.BbvCI nicking site on the vector, these 25 bp
will regenerate the PacI cassette upon insertion, and
enable further USER cloning of fragments into this vector.
Sequential USER cloning of DNA fragments into vectors is
particularly useful for vector construction. As an example,
a vector suitable for translational fusions to YFP was
constructed by USER cloning the YFP gene into the USER
compatible Xenopus expression vector, pNB1u (Table 1).
By including 25 bp of the PacI cassette sequence in the
reverse primer used to amplify the YFP gene, the full PacI
Figure 2. Characteristics and applications of the USER technique. (a) A comparison of the ability of DNA polymerases to amplify DNA fragments using uracil-
free (-dU) and uracil-containing primers (+dU). Hm Taq: HotMaster  Taq DNA Polymerase, Taq: Platinum  Taq DNA Polymerase, Pwo: Pwo DNA
Polymerase, Phusion: Phusion  DNA Polymerase, PfuCx: PfuTurbo  Cx Hotstart DNA polymerase. (b) Functional expression of A.thaliana glucose transporter
AtSTP1 in X.laevis oocytes from the Xenopus-specific USER compatible vector, pNB1u. H2O: control oocytes injected with water; STP1: oocytes injected with
AtSTP1 cRNA. (c) Functional expression of the cyano fluorescence protein in leaf and root of A.thaliana from the CaMV 35S promoter using the USER
compatible pCAMBIA230035Su vector (35S:CFP). Control: empty pCAMBIA230035Su.
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upon insertion of the fragment (exempliﬁed in Figure 3,
DNA of interest denotes the YFP gene). The distance
between the YFP coding sequence and a subsequently
inserted gene (through USER cloning) would be 13 bp
(Figure 3) and would thus bring the inserted fragment out
of the YFP reading frame. Therefore, the reverse primer
used to amplify the YFP gene had an extra two cytidine resi-
dues added between the 25 bp sequence and the YFP ORF
speciﬁc sequence (see Materials and Methods). This design
ensured that subsequent digestion of the YFP containing
pNB1u vector with PacI and Nt.BbvCI enabled USER
cloning of DNA fragments into the vector downstream of
and in frame with the YFP tag and hence would result in
N-terminal YFP fusion constructs. With this approach, we
inserted YFP (17), YFP-based bimolecular ﬂuorescence
complementation (BiFC) tags (18) and RGSHis6 tags into
our existing USER vectors to construct a comprehensive set
of C- and N-terminal translational fusion vectors for sub-
cellular localization, protein–protein interaction and protein
puriﬁcation studies, respectively. For a full-list of our vectors,
see Table 1. The efﬁcacy of the vectors has been veriﬁed
experimentally and had a cloning efﬁciency of approximately
100–200 colonies per 0.01 pmol of vector when mixed with
at least 4-fold molar excess of PCR fragment. Moreover,
the percentage of recombinant colonies exceeds 95% when
the molar ratio of vector:PCR fragment is above 1:2 (data
not shown). This is fully comparable to the cloning efﬁciency
observed by NEB with their USER vector (http://www.neb.
com/nebecomm/ManualFiles/manualE5500.pdf).
DISCUSSION
The uracil-excision based cloning technique has although it
holds some very favorable features, not been widely applied
as evidenced by the lack of citations in the literature. In this
study, we have provided signiﬁcant improvements which in
our view have contributed to creating an ideal cloning tech-
nique for insertion of PCR ampliﬁed fragments into vectors.
We have shown that the modiﬁed Pfu polymerase, PfuCx,
is a highly suitable, proof-reading DNA polymerase to be
used in conjuction with USER cloning. This polymerase
was developed in 2002 in a study, which examined the
structural basis for uracil inhibition of proof-reading poly-
merases via a targeted point mutation approach of the Pfu
polymerase (10). Normally, uracil residues are introduced
in DNA templates due to spontaneous deamination of dCTP
to dUTP (19). Proof-reading enzymes are able to detect and
stall at uracil residues in the template as these represent a pro-
mutagenic event generating G-C to A-T mutations (20). This
stalling has deleterious effects on PCR product yield where
spontaneous deamination of dCTP occurs more frequently
during temperature cycling (19). In this context, PfuCx has
been promoted as a proof-reading polymerase which, due to
its ability to read through uracils, has a more robust perfor-
mance and a higher yield. In this study, PfuCx is shown to
be able to utilize uracil containing primers to amplify DNA
fragments with high-ﬁdelity for cloning purposes with the
uracil excision technique. By identifying a USER compatible
proof-reading DNA polymerase, we have overcome a major
drawback of the currently existing USER  cloning tech-
nique. It is important to note that DNA fragments ampliﬁed
with the PfuCx polymerase for USER cloning will be suscep-
tible to have deaminated dCTPs incorporated in the template.
Due to the high ﬁdelity of the PfuCx polymerase only few
errors have been observed in our sequencing of USER cloned
DNA fragments and thus do not provide sufﬁcient data
to show whether G-C to A-T substitutions occur more fre-
quently when using PfuCx. Nevertheless, it is possible that
the ﬁdelity of the system could be enhanced by including a
dUTPase in the polymerase enzyme mix. Thereby, generated
dUTPs would be degraded to dUMPs which cannot be
incorporated in DNA strands during PCR (19).
A second improvement to the existing commercial
USER  technique, is the advancement of the vector design
strategy. First, the cassette used to convert vectors was modi-
ﬁed to accommodate a much wider range of vectors. The
vector conversion approach developed by NEB involves
insertion of XbaI-containing cassettes into the multiple
cloning sites of vectors. This imposes a limit on the range
of convertable vectors as statistically XbaI recognition sites
occur every 4096 bp and therefore can be expected to be pre-
sent in many vectors. This is particularly a problem when
working with large vectors, such as those required for plant
Figure 3. Sequential USER cloning of multiple inserts. Inclusion of 25 bp of
the PacI cassette sequence in the reverse primer used to amplify a DNA
fragment prior to USER cloning results in regeneration of the PacI cassette
downstream of the inserted fragment. For smaller fragments the entire insert
can be assembled from chemically synthesized oligonucleotides. Subsequent
digestion of the construct with PacI and Nt.BbvCI allows insertion of another
fragment into the vector by USER cloning. Sequentially inserted DNA
fragments will have a minimum of 13 bp sequence between them. Nt.BbvCI
recognition sites are marked in tan, PacI recognition sites are marked in light
blue. Yellow and green mark the single base differences between the
generated 30 overhangs.
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8 bp PacI recognition site, which statistically only occurs
every 65 536 bp, this problem has signiﬁcantly been reduced,
while at the same time preserving the directional insertion of
the DNA fragments. Second, we have developed a strategy
for sequential USER cloning of multiple inserts into the
same vector. The method relies on regenerating the PacI cas-
sette when USER cloning fragments into the ﬁrst cassette.
This is done by including a large part of the PacI cassette
sequence in the inserted DNA fragment. Thus, for any given
vector design only one initial restriction-ligation based
insertion of a PacI cassette is necessary. This feature greatly
facilitates the construction and modiﬁcation of any vector,
and is particular useful when working with large vectors
which commonly have a very limited selection of unique
restriction sites. Furthermore, it enables researchers to keep
up with the rapid development in e.g. peptide tags by allow-
ing easy upgrading of their favorite vectors.
The improved USER cloning technique combines several
advantageous features from various existing cloning
techniques. DNA fragments are directionally inserted into
destination vectors by an approach, which is as straight-
forward and fast as that of the commercial USER  cloning
technique while having the high ﬁdelity enjoyed by
most other established cloning techniques. The simplicity of
the USER cloning technique is comparable to that of
topoisomerase-assisted cloning (21), while the low cost per
cloning reaction is comparable to that of classical restriction-
ligation based cloning. With respect to the improved design
strategy of USER vectors the transparency, ﬂexibility and
inexpensiveness endows the researcher with complete control
over the vector design independent of commercial vendors.
This is demonstrated by our ability to rapidly generate a
comprehensive set of vectors covering a wide range of
applications, such as constitutive expression in a variety of
host organisms as well as protein–protein interaction and sub-
cellular localization studies (Table 1). Furthermore, because
the same PacI cassette has been used to generate all our
USER vectors, any fragment that has been PCR ampliﬁed
with primers containing the described 8 bp tails can be
inserted into all our vectors, much like in the concept of
recombination-based Gateway  system (Invitrogen), where
fragments which have been inserted into entry clones can
be transferred to many destination vectors. In comparison
to the currently dominating Gateway  cloning technique,
the improved USER cloning technique presents several
advantages when cloning a PCR fragment into a vector.
Primers for PCR need to have tails of only 8 bp compared
to 29 bp for Gateway  primers (http://www.invitrogen.com/
content/sfs/manuals/ gateway_clonaseii_man.pdf), which rep-
resents a signiﬁcant reduction in risk of errors and in cost.
In addition, in the USER technique fragments are inserted
directly into destination vectors while Gateway  requires
an extra, time-consuming subcloning step via the entry vec-
tor. However, the entry clone concept of Gateway  is advan-
tageous to the USER technique when neededing to transfer
the exact same PCR fragment into many vectors. Via recomb-
ination, fragments are transferred into the different destina-
tion vectors without the need for further sequencing while
each cloning event in the USER technique involves insertion
of a PCR product, and consequently requires sequence
veriﬁcation. However, the simplicity, high efﬁciency, ﬁdelity,
low cost and ﬂexibility of the improved USER technique
compensate for this by overall reduction in laboratory work
time. There is an increasing demand for high-throughput
methods for insertion of PCR fragments into vectors, e.g.
for creating clone libraries. The improved USER cloning
technique is exceptionally powerful in this respect, which
was evident in a recent study where we transferred 216
different A.thaliana genes, into a USER-compatible vector
with an efﬁciency as high as 96% (H. H. Nour-Eldin,
M. H. H. Nørholm and B. A. Halkier, manuscript submitted).
The entire procedure took approximately one week and
included two rounds of validation via PCR on colonies
where we tested one colony per plate per round of validation.
Moreover, the procedure proved to be very easy to auto-
mate. In this way, the Gateway  technique and other recomb-
ination based cloning techniques could beneﬁt from the
improved USER technique when generating similar libraries
by inserting the PacI cassette between recombination sites in
their entry vectors. Finally, when sequentially USER cloning
multiple fragments into our USER vectors to generate e.g.
translational fusion constructs only 15 bp will remain at the
junction between the inserted fragments. Thus, even though
the improved USER technique is not completely seamless,
it represents a signiﬁcant improvement compared to the
Gateway  system, which leaves a minimum of 24 bp (22).
Moreover, the approach described in this study for generating
translational fusions is ﬂexible and may be improved by using
other combinations of restriction and nicking enzymes in
the cassette.
In conclusion, the ability to use a proof-reading DNA
polymerase to amplify DNA fragments for USER cloning
experiments in combination with our vector design approach
has, in our view, generated an ideal technique for cloning
PCR fragments into vectors.
With completion of the genome sequencing projects, the
next major challenge is to identify the functional role of the
genes. High-throughput techniques to directionally transfer
error-free DNA fragments into a given vector represent a
critical bottleneck. The improved USER technique provides
the means to efﬁciently overcome this bottleneck and based
on the impact on the cloning throughput in our laboratories,
we believe that this technique will be able to move molecular
biology into an era where the cloning step occupies only a
minor part of a molecular research project.
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